|
Age class
|
AMA-1
|
MSP-1
|
Combined
|
|---|
|
(years)
|
n
|
No. Pos.
|
% Pos.
|
n
|
No. Pos.
|
% Pos.
|
N
|
No. Pos.
|
% Pos.
|
|---|
|
2 to 5
|
61
|
4
|
6.6
|
61
|
5
|
8.2
|
61
|
6
|
9.8
|
|
6 to 9
|
190
|
26
|
13.7
|
189
|
15
|
7.9
|
190
|
35
|
18.4
|
|
9 to 13
|
216
|
33
|
15.3
|
193
|
42
|
21.8
|
216
|
58
|
26.9
|
|
14 to 17
|
154
|
25
|
16.2
|
129
|
36
|
27.9
|
154
|
46
|
29.9
|
|
18 to 20
|
63
|
16
|
25.4
|
60
|
22
|
36.7
|
63
|
29
|
46.0
|
|
21 to 29
|
40
|
14
|
35.0
|
40
|
15
|
37.5
|
40
|
15
|
37.5
|
|
30 to 49
|
50
|
26
|
52.0
|
48
|
23
|
47.9
|
50
|
30
|
60.0
|
|
over 50
|
41
|
28
|
68.3
|
39
|
21
|
53.8
|
41
|
28
|
68.3
|
|
Total
|
815
|
172
|
21.1
|
759
|
179
|
23.6
|
815
|
247
|
30.3
|
- The number of total samples, positive results, and prevalence for each age class appear for participants with positive ELISA results toward AMA-1, MSP-1, or either AMA-1 or MSP-1 antigens.
